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Akt ratio in OC explants early after NF-  B inhibition. Finally, 
we observed an early and consistent decrease in the phos-
pho-p38/p38 ratio in OC explants exposed to the NF-  B in-
hibitor and only a transient decrease in this ratio in OC ex-
amples after gentamicin exposure. 
 Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Hearing loss due to sensorineural damage has been 
recognized for over a century. Until recently, damage to 
cochlear hair cells (HCs) and neurons has been regarded 
as an inevitable consequence of age, genetic conditions or 
exposure to certain environmental stimuli. During the 
past several years, however, some of the critical intracel-
lular events that mediate aspects of damage to HCs have 
been discovered [Cheng et al., 2005; Matsui and Co-
tanche, 2004]. In a large number of studies, aminoglyco-
sides have been utilized as inducers of HC death, and a 
significant progress in understanding aminoglycoside-
induced HC death has been made [Lautermann et al., 
2004; Rybak and Whitworth, 2005]. After aminoglyco-
side exposure, cellular and biochemical alterations in the 
HCs of the organ of Corti (OC) are set into motion. Reac-
tive oxygen species have been detected in vitro soon after 
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 Abstract 
 Studies conducted over the last few years demonstrated 
that signaling pathways that operate in the organs of Corti 
(OC) play a central role in survival and death of hair cells. An 
important goal of molecular otology is to characterize these 
signaling pathways in normal inner ears and inner ears ex-
posed to a variety of different forms of stress, such as oto-
toxic substances and noise overexposure. In this study, we 
used high-performance reverse protein microarray technol-
ogy and phospho-specific antibodies to examine the activa-
tion status of defined molecules involved in cellular signal-
ing. We demonstrate that reverse protein microarrays based 
on the highly sensitive planar-waveguide technology pro-
vide an effective and high-throughput means to assess the 
activation state of key molecules involved in apoptotic and 
prosurvival signaling in microdissected OC explants over 
time. In this study, we show that gentamicin and a specific 
NF-  B inhibitor increase the ratio of phospho-c-Jun/c-Jun in 
OC explants of postnatal rats soon after exposure to these 
drugs. In addition, we found a decrease in the phospho-Akt/
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exposure to aminoglycosides [Priuska and Schacht, 1995; 
Sha et al., 2001; Choung et al., 2009]. In addition, it has 
been demonstrated that small GTPases, such as Ras and 
Rho/Rac/Cdc42, as well as the c-Jun-N-terminal kinase 
(JNK) signaling pathway, are activated in cells exposed to 
the drug [Battaglia et al., 2003; Bodmer et al., 2002a, b; 
Pirvola et al., 2000; Jiang et al., 2006a]. JNK activation 
results in phosphorylation of c-Jun and in activation of 
the transcription factor activating protein-1 complex
[Albinger et al., 2006; Matsui et al., 2004]. Finally, cas-
pases are activated and HCs undergo apoptotic cell death 
after prolonged aminoglycoside exposure [Huang et al., 
2000; Okuda et al., 2005]. However, chronic administra-
tion of aminoglycosides induces also caspase-indepen-
dent pathways of HC death [Jiang et al., 2006b].
 Interestingly, gentamicin exposure also activates path-
ways that promote HC survival [Battaglia et al., 2003]. 
This is in agreement with the current opinion that cells 
are thought to exist in a finely tuned balance between 
survival and cell death [Boatright and Salvesen, 2003; 
Raff, 1992]. According to this concept, exposure to cel-
lular stress disrupts this balance and if the stress is severe, 
apoptosis-promoting pathways predominate and the cells 
die. 
 Lately, survival pathways which operate in HCs have 
been defined. One such pathway is the H-Ras/Raf/MEK/
Erk pathway [Battaglia et al., 2003]. Another pathway is 
the phosphatidylinositol-3 kinase (PI3k) pathway. In an 
interesting publication by Chung et al. [2006], it has been 
shown that PI3k mediates HC survival and opposes gen-
tamicin toxicity in neonatal rat OC explants via its down-
stream target, the protein kinase Akt. This finding is in 
good agreement with data from our laboratory. We dem-
onstrated recently that the transcription factor NF-  B is 
required for survival of immature auditory HC in vitro 
 [Nagy et al., 2005, 2007] in a PI3k-dependent pathway. In 
addition, in an interesting publication by Schacht and 
colleagues, it has been shown that the aminoglycoside
kanamycin stimulates the activation of NF-  B and that 
this activation protects cochlear HCs from aminoglyco-
side-induced ototoxicity [Jiang et al., 2005].
 Reversible protein phosphorylation is one of the most 
abundant posttranslational modifications. Protein ki-
nases transfer a phosphate group from adenosine tri-
phosphate to serine, threonine or tyrosine residues. This 
process is reversible, and dephosphorylation occurs by 
enzymes called phosphatases. Protein kinases and pro-
tein phosphatases are regulated by extracellular stimuli, 
and the activity of these enzymes leads to dynamic chang-
es in protein phosphorylation and subsequently deter-
mines whether a signal transduction pathway is turned 
on or switched off. In order to gain insight into the mo-
lecular mechanisms involved in these processes, the 
phosphorylation status of key molecules involved in HC 
damage/death and survival need to be investigated. In 
this study, we used highly sensitive reverse protein micro-
arrays which allow generating high-fidelity data for pro-
tein expression profiling of low levels or transient states 
of protein abundance [Pawlak et al., 2002; Weissenstein 
et al., 2006; Oostrum and Voshol, 2008]. We wanted to 
apply this new technology, namely planar-waveguide
reverse protein microarrays, to the characterization and 
direct monitoring of the activity and protein phosphor-
ylation of key molecules involved in apoptotic and pro-
survival signaling in the OC. We hoped that the high
sensitivity of the method would allow the parallel analy-
sis of the phosphorylation status of several selected sig-
naling marker proteins in single microdissected OC ex-
plants.
 During the last decades, ELISAs have been used to 
measure the expression level of a defined single protein. 
However, ELISA applications are often laborious, and 
time- and material-consuming. In contrast, protein ar-
rays have the potential to analyze a multiple set of pro-
teins simultaneously in only minute amounts of a bio-
logical sample. Protein arrays are mostly based on trans-
lating the well-established single-analyte ELISA assay 
format into a miniaturized, multiplexed assay combined 
with chemiluminescence or fluorescence readout [Trem-
plin et al., 2002]. In order to achieve adequate sensitivity 
for the signal detection, various amplification schemes 
have been developed. Zeptosens has developed a micro-
array system based on planar waveguide technology fea-
turing an advanced surface-confined fluorescence signal 
generation and read-out scheme providing very high sen-
sitivity while using less reagent and sample material com-
pared to other microarray systems (www.zeptosens.com) 
[Pawlak et al., 2002]. While the inner ear offers only tiny 
amounts of tissue for analysis, we tested this protein array 
system for its potential use in inner ear research. 
 For the analysis, we chose two members of apoptosis 
signaling pathways (c-Jun and p38) and one member of a 
survival pathway (Akt). We investigated the ratios of the 
cellular levels of phosphorylated versus nonphosphory-
lated forms of the transcription factor c-Jun and of the 
protein kinase Akt over time in OC cultures exposed to 
either gentamicin or to an NF-  B inhibitory peptide. In 
addition, we analyzed the expression levels of phosphor-
ylated versus nonphosphorylated forms of p38, a protein 
kinase involved in apoptosis and cell survival pathways. 
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 Material and Methods 
 Tissue Culture 
 All animal procedures were carried out according to an ap-
proved animal research protocol (Kantonales Veterinaeramt, Ba-
sel, Switzerland). For tissue culture, 5- to 6-day-old Wistar rat pups 
were used. The rats were killed, and cochlear microdissections 
were performed under a light microscope to isolate the OC, spiral 
ganglion, and stria vascularis [Sobkowicz et al., 1993]. After isola-
tion, all OCs were transferred to cell culture plates and maintained 
on 0.4-mm culture plate inserts (Millipore) in Dulbecco Modified 
Eagle Medium with 25  M HEPES supplemented with 10% fetal calf 
serum (all Invitrogen) and 30 U/ml penicillin (Sigma). 
 Gentamicin Time Course Experiment 
 OCs were obtained as described above. They were maintained 
for 48 h in culture medium for recovery. OCs were then exposed 
to gentamicin at the concentration of 0.5 m M for 2, 4, 6, 9, and
15 h. We recently demonstrated that this concentration of genta-
micin results in significant HC loss after 15 h [Caelers et al., 2009]. 
Control explants were maintained in culture medium alone for 0 
and 15 h. For each time point, 1 OC was studied. Each experiment 
was repeated three times for both conditions (culture medium 
alone or gentamicin treatment). After culturing, OC explants 
were lysed in 40   l of CLB96 buffer (Zeptosens).
 NF-  B Inhibition Time Course Experiment 
 To inhibit NF-  B activity, an HPLC-purified synthetic inhib-
itor (NF-  B inhibitor, AAVALLPAVLLALLAPVQRKRQKLMP, 
Santa Cruz Biotechnology, Inc., Santa Cruz, Calif., USA) was used 
at the final concentration of 25   g/ml in culture medium. We 
have previously shown that this compound at this concentration 
causes HC loss within several hours [Nagy et al., 2005]. OCs were 
obtained as described above. They were maintained for 48 h in 
culture medium for recovery. OCs were then exposed to the NF-
  B inhibitor at the concentration of 25   g/ml for 2, 6, and 15 h. 
Control explants were maintained in culture medium alone for 0 
and 15 h. For each time point, 1 OC was studied. Each experiment 
was repeated three times for both conditions (culture medium 
alone or NF-  B inhibitor treatment). After culturing, OC ex-
plants were lysed in 40   l of CLB96 buffer (Zeptosens).
 Microarray Printing, Blocking, and Analysis 
 Microarrays were produced employing a standard protocol as 
described in detail [Oostrum et al., 2009]. Briefly, total protein 
lysates were spotted in serial fourfold dilutions on ZeptoMARK 
hydrophobic chips (Zeptosens) as droplets of 400 pl in duplicate 
with a noncontact piezoelectric microdispenser (Nanoplotter 2.0, 
GeSiM). Chips were dried for 1 h at 37 ° C and were blocked with 
blocking buffer BB1 for 20 min using the ZeptoFOG ultrasonic 
nebulizer (Zeptosens). After blocking, the chips were washed 
with water and spin-dried in a swinging-bucket centrifuge with 
an appropriate holder (available from Zeptosens) at 200  g for
3 min. The chips were stored at 4 ° C in the dark until use in reverse 
protein microarray assays. Each of the three biological replicates 
(independently treated OC explants) was analyzed in two inde-
pendent microarray experiments.
 For relative quantification of the immobilized proteins, chips 
were blocked with 1% Tween-80 in water following a similar pro-
tocol as described above. After the washing steps and drying, the 
chips were incubated with filtered Sypro Ruby Protein Dye (Invi-
trogen), diluted 1: 5 in water for 30 min and were washed again 
three times. Relative amounts of immobilized total protein lysates 
were quantified using the green detection channel (  ex/  em = 
532/570 nm) of a ZeptoREADER (Zeptosens).
 BB1-blocked chips were used for high-performance protein 
microarrays analysis. The chips were incubated with antibodies 
to phospho-(Thr308)-Akt, Akt, phospho-(Ser73)-c-Jun, c-Jun, 
phospho-(Thr180, Tyr182)-p38 MAPK and p38 MAPK in assay 
buffer CAB1 (Zeptosens) overnight. Then, after rinsing the chips 
with CAB1 three times, an incubation step with corresponding 
fluorophore-labeled anti-species antibodies (Alexa647-labeled 
rabbit or mouse Fab, Invitrogen Z25308 or Z25108, respectively) 
followed. After another wash cycle, protein phosphorylation was 
assessed by measuring fluorescence intensities in the red channel 
(  ex/  em = 635/670 nm) of a ZeptoREADER (Zeptosens). Im-
ages were analyzed with the ZeptoVIEW pro image processing 
software (version 2.0, Zeptosens), and relative fluorescence inten-
sities were calculated by plotting of net spot intensities relative to 
protein concentration as described [Pawlak et al., 2002; Oostrum 
et al., 2009] and normalized to the relative amount of immobi-
lized protein. Errors were calculated with Gauss’ error progres-
sion.
 ELISA Assay 
 An ELISA assay was used to quantify total Akt and phospho-
Akt according to the manufacturer’s protocol (R&D Systems). 
Briefly, all OC explants were maintained for 24 h in culture me-
dium. Further, OC explants were cultured in fresh culture me-
dium alone for 6 or 15 h (control), or were exposed to the NF-  B 
inhibitor at the concentration of 25   g/ml for 6 or 15 h. The ex-
plants were then used for ELISA analysis to determine phospho-
Akt and Akt in the two groups. The data were collected from four 
independent experiments and statistically analyzed (Student’s t 
test). 
 Western Blot (Antibody Validation) 
 The following phospho-specific antibodies were tested for 
their selectivity for the phosphorylated epitope: phospho-
(Thr308)-Akt, phospho-(Ser73)-c-Jun, phospho-(Thr180, Tyr182)-
p38 MAPK. Antibodies were tested for specificity at a 1: 1000 dilu-
tion by Western Blotting as described [Towbin et al., 1979] using 
whole cell extracts from untreated, calyculin-treated (induction of 
Akt phosphorylation), UV-irradiated (induction of c-Jun phos-
phorylation) or anisomycin-treated (induction of p38 phosphory-
lation) HeLa cells according to a protocol by Zepto sens.
 Results 
 Gentamicin Exposure or Exposure of OC Explants 
to the NF-  B Inhibitor Results in an Increase in the 
Phospho-c-Jun/c-Jun Ratio  
 A time course analysis of the phospho-c-Jun to total 
c-Jun protein ratio reveals a significant increase in OC 
explants exposed to 0.5 m M gentamicin for 6 h ( fig. 1 a) or 
2 h of the NF-  B inhibitor at the concentration of 25   g/
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ml ( fig. 1 b), as compared to control explants. The peak 
ratio can be observed after 9 h of gentamicin exposure 
and 6 h of exposure to the NF-  B inhibitor. Cell cultur-
ing itself does not change the phospho-c-Jun/c-Jun ratio, 
as we observe no difference when OC explants are held in 
culture medium alone (0 and 15 h). 
 Exposure of OC Explants to the NF-  B Inhibitor 
Results in a Decrease in the Phospho-Akt/Akt Ratio
and Gentamicin Exposure Does Not Change the 
Phospho-Akt/Akt Ratio over Time 
 A time course analysis of the phospho-Akt to total Akt 
protein ratio reveals a decrease in the phospho-Akt/Akt 
ratio in OC explants when exposed to the NF-  B inhibi-
tor for 2 and 6 h ( fig. 2 a), with a minimum of the phos-
pho-Akt/Akt ratio after 6 h of exposure as compared to 
control explants. An independent ELISA experiment 
confirmed the decrease in the phospho-Akt/Akt ratio in 
OC explants exposed to the NF-  B inhibitor for 6 h as 
compared to control explants maintained in culture me-
dium alone for 6 h ( fig. 3 ). Exposure of OC explants to 
gentamicin does not change significantly the phospho-
Akt/Akt ratio over time as revealed by the analysis of the 
array data ( fig. 2 b) or the ELISA analysis ( fig. 4 ). Cell cul-
turing itself does not change the phospho-Akt/Akt ratio, 
as we observe no difference when OC explants are held in 
culture medium alone (0 and 15 h). 
 Gentamicin Exposure or Exposure of OC Explants to 
the NF-  B Inhibitor Results in an Early Decrease in 
the Phospho-p38/p38 Ratio  
 A time course analysis of the phospho-p38 to total p38 
protein ratio reveals a significant decrease in the phospho-
p38/p38 ratio in OC explants exposed to 0.5 m M gentami-
cin for 4 h ( fig. 5 a) or the NF-  B inhibitor at the concen-
tration of 25   g/ml for 2, 6, and 15 h ( fig. 5 b), as compared 
to control explants. The decrease in the ratio occurs early 
after gentamicin exposure (minimum after 4 h) or expo-
sure to the NF-  B inhibitor (minimum after 6 h). Interest-
ingly, the phospho-p38/p38 ratio increases after the initial 
drop in the gentamicin-treated samples, while the samples 
treated with the NF-  B inhibitor display a permanent de-
crease in the ratio over time. Cell culturing itself also 
changes the phospho-p38/p38 ratio, as we observe a de-
crease in the ratio when OC explants are held in culture 
medium alone for differing lengths (0 and 15 h). 
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 Fig. 1. Activation profile of c-Jun in OC explants represented as 
phospho-(Ser73)-c-Jun vs. total c-Jun protein ratio. OC explants 
were treated with gentamicin ( a ) or the NF-  B inhibitor (NF  BI; 
b ) for the indicated times before lysis and subsequent microarray 
analysis. Each bar in the diagram represents the mean of three 
biological replicates (independently treated OC explants), which 
were analyzed in two independent microarray experiments. As-
terisks indicate a statistically significant (p  ! 0.05) difference be-
tween the indicated groups. Errors are calculated with a Gauss 
error progression. Histograms represent mean + standard devia-
tion. RFI = Relative fluorescence intensity. 
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 Fig. 2. Activation profile of Akt in OC explants represented as 
phospho-(Thr308)-Akt vs. total Akt protein ratio. OC explants 
were treated with the NF  BI ( a ) or gentamicin ( b ) for the indi-
cated times before lysis and subsequent microarray analysis. Each 
bar in the diagram represents the mean of three biological repli-
cates (independently treated OC explants), which were analyzed 
in two independent microarray experiments. Asterisks indicate a 
statistically significant (p  ! 0.05) difference between the indicat-
ed groups. Errors are calculated with a Gauss error progression. 
Histograms represent mean + standard deviation.  
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 Fig. 4. Phospho-Akt/Akt ratio as determined by ELISA analysis. 
OC explants were held in culture medium alone or treated with 
gentamicin for the indicated time before ELISA analysis. Each bar 
in the diagram represents the mean of four biological replicates 
(independently treated OC explants) + standard deviation. The 
changes in the phospho-Akt/Akt ratio in the different groups 
were not statistically significant. 
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 Fig. 3. Phospho-Akt/Akt ratio as determined by ELISA analysis. 
OC explants were held in culture medium alone or treated with 
the NF  BI for the indicated time before ELISA analysis. Each bar 
in the diagram represents the mean of five biological replicates 
(independently treated OC explants) + standard deviation. The 
decrease in the phospho-Akt/Akt ratio after NF-  B inhibition 
was statistically significant (p  ! 0.05). 
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 Anti-Phospho Antibodies Used Detect a Single Species 
in Western Blots 
 Western blot analysis revealed that the antibodies
used in this study (antibodies against phospho-c-Jun, 
phospho-Akt, phospho-p38) detect just a single species 
( fig. 6 ). 
 Discussion 
 The goal of this study was to investigate whether the 
planar-waveguide reverse protein microarrays can be 
used as a tool to analyze signal transduction events upon 
damage in the OC. The advantage of this new technology 
is that it is highly sensitive, so that a single OC can be 
probed with multiple antibodies. Therefore, precious ma-
terial can be saved and fewer animals have to be sacri-
ficed. A further advantage of this method is that even 
transient modifications of proteins, such as phosphopro-
teins, can be analyzed. However, the analysis of phospho-
proteins is based on phospho-specific antibodies that are 
sometimes insensitive to cross-reactivity since the se-
quence around the phosphorylated residue is highly con-
served. To demonstrate that the phospho-specific anti-
bodies used in this study are specific, we used Western 
blots to show that the antibodies used detect a single spe-
cies ( fig. 6 ). In the literature so far, several pathways have 
been implicated in damage to the OC. Here, we have used 
this new method to study some of these pathways. It 
should be noted that our in vitro  data presented here are 
limited to newborn rat pups, because only OCs from 
newborn animals can be used for tissue culture. However, 
the immature cochlea is an established model for the 
study of aminoglycoside toxicity [Pirvola et al., 2000]. 
Still, in vitro toxicity assessed in neonatal tissue may oc-
cur by different mechanisms than in vivo toxicity in 
adults. As an example, it has been demonstrated that 
high-dose aminoglycoside treatment in vitro can lead to 
rapid blebbing of the apical HC surface [Richardson and 
Russel, 1991]. This phenomenon has not been observed in 
vivo . Therefore, we used relatively low gentamicin dos-
ages (0.5 m M ) to mimic features of adult in vivo  toxicity. 
 In line with the literature, the data of the present study 
demonstrate that the JNK pathway is involved in HC loss 
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 Fig. 5. Activation profile of p38 in OC explants represented as 
phospho-(Thr180, Tyr182)-p38 MAPK vs. total p38 MAPK pro-
tein ratio. OC explants were treated with gentamicin ( a ) or the 
NF  BI ( b ) for the indicated times before lysis and subsequent mi-
croarray analysis. Each bar in the diagram represents the mean of 
three biological replicates (independently treated OC explants), 
which were analyzed in two independent microarray experi-
ments. Asterisks indicate a statistically significant (p  ! 0.05) dif-
ference between the indicated groups. Errors are calculated with 
a Gauss error progression. Histograms represent mean + standard 
deviation.  
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due to aminoglycoside gentamicin. Since JNK activation 
results in phosphorylation of c-Jun in HC nuclei [Bodmer 
et al., 2002a, b; Pirvola et al., 2000], we used this pathway 
as a reference to test whether our array data would dem-
onstrate the same findings. We show that the phosphory-
lated c-Jun to c-Jun ratio increases in OC explants ex-
posed to 0.5 m M gentamicin for 6 and 9 h ( fig. 1 ). This 
observation is in good agreement with the literature 
[Matsui and Cotanche, 2004; Pirvola et al., 2000]. We ob-
served a peak of phosphorylated c-Jun/c-Jun in OC ex-
plants after 9 h of exposure to gentamicin. This fits well 
with our previous observation that phosphorylated c-Jun 
can be seen in outer and inner HCs of the OC 12 h af-
ter gentamicin exposure using immunohistochemistry 
[Bodmer et al., 2002a]. Cell culturing of OC explants in 
medium alone does not seem to activate the JNK signal-
ing pathway, as we observed the same ratio of phospho-
c-Jun/c-Jun after culturing OC explants for 0 and 15 h 
without gentamicin treatment ( fig. 1 a). NF-  B inhibition 
also led to activation of the JNK signaling pathway: we 
observed an increase in phosphorylated c-Jun/c-Jun in 
OC explants after 6 h of NF-  B inhibition as compared 
to control OC explants maintained in culture medium 
alone ( fig. 1 b). Taken together, our results concerning the 
JNK pathway are in good agreement with the literature, 
and therefore suggest that this new technology is a pow-
erful tool for the analysis of signaling events in cultured 
OC explants.
 We have previously shown that NF-  B inhibition re-
sults in rapid HC loss from cultured OC explants [Nagy 
et al., 2005]. In a follow-up study using gene arrays and a 
biochemical assay, we were able to link the NF-  B-in-
duced HC loss to PI3k [Nagy et al., 2007]. Interestingly, 
the PI3k pathway has been previously linked to HC sur-
vival [Chung et al., 2006] and to aminoglycosides [Schacht 
et al., 1977; Jiang et al., 2006c]. Activated PI3k phosphor-
ylates the membrane lipid PIP2 at the 3  -OH position to 
generate PIP3. PIP3 recruits signaling proteins such as 
Akt and PDK-1. The activation state of Akt is an indicator 
of the state of the PI3k survival pathway. In this study, we 
observed an early decrease in the phospho-Akt/Akt ratio 
in OC explants exposed to an NF-  B inhibitor as com-
pared to control OC explants maintained in cell culture 
medium alone ( fig. 2 a). Using an ELISA analysis, we were 
able to confirm the protein microarray data: OC explants 
exposed to the NF-  B inhibitor also demonstrated a de-
crease in the phospho-Akt/Akt ratio as compared to con-
trol explants maintained in culture medium alone for the 
same time period (6 h;  fig. 3 ). The decrease was more sig-
nificant with ELISA than it was with the array. It might 
be that this quantitative difference in the phospho-Akt/
Akt ratio using the two methods is due to the cross-reac-
tivity that might have occurred using the ELISA kit or 
due to the possibility that ELISA might have been some-
what more sensitive in this particular case. In contrast to 
the situation in OC explants treated with the NF-  B in-
M
Untreated
Phospho-c-Jun
UV treatment
A B C D
Phospho-p38
A B C D M
Untreated Anisomycin treatment
Phospho-Akt
Untreated Calyculin treatment
A B C D M
a
b
c
 Fig. 6.  a Western blot analysis demonstrates the presence of a sin-
gle species (arrow) detected by the antibody against phospho-c-
Jun in HeLa cells after UV treatment (lane C). Untreated HeLa 
cells with the secondary antibody only (lane A), untreated HeLa 
cells with primary and secondary antibody (lane B), and treated 
HeLa cells with the secondary antibody only (lane D) do not show 
this band. M = Molecular marker.  b Western blot analysis dem-
onstrates the presence of a single species (arrow) detected by the 
antibody against phospho-p38 in HeLa cells after anisomycin 
treatment (lane C). Untreated HeLa cells with the secondary an-
tibody only (lane A), untreated HeLa cells with primary and sec-
ondary antibody (lane B), and treated HeLa cells with the second-
ary antibody only (lane D) do not show this band.  c Western blot 
analysis demonstrates the presence of a single species (arrow) de-
tected by the antibody against phospho-Akt in untreated HeLa 
cells (lane B) and after calyculin treatment (lane C). Untreated 
HeLa cells with the secondary antibody only (lane A) and treated 
HeLa cells with the secondary antibody only (lane D) do not show 
this band.  
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